Teva intros generic Relpax

Teva intros generic Relpax

NORTH WALES, Pa. — Teva on Wednesday announced the launch of its generic of Relpax (eletriptan HBr) tablets. The drug is indicated to treat migraine headaches.

ChemSpider 2D Image | 3-{[(2R)-1-Methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indolhydrobromid | C22H27BrN2O2S

“Our customers count on Teva for a continuous supply of new generic products,” Teva North American generics COO Maureen Cavanaugh said. “With the launch of eletriptan hydrobromide tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”

August 5, 2017


August 9, 2017 / Pharma News